IMNM
Immunome Inc
21.20$
+1.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -241.6% | -456.3% | -1,085.5% | -989.7% | -1,174.1% | -1,536.2% | -1,813.2% | -1,230.4% | – | – | – | – | – | |
| 4.7% | 6.7% | 25.6% | 28.5% | 19.6% | 21.7% | 24.8% | 17.9% | – | – | – | – | – | |
| 30.4% | 75.4% | 209.8% | 136.5% | 168.1% | 199.8% | 194.9% | 133.2% | – | – | – | – | – | |
| -164.1% | -207.1% | 435.8% | 121.2% | 76.9% | 193.1% | -581.9% | -292.8% | – | – | – | – | – | |
| 1.0% | 9.1% | 210.3% | 99.2% | 52.9% | 50.2% | 125.3% | 22.5% | – | – | – | – | – | |
| -1.0% | -784.2% | -3,618.2% | -3,455.5% | 828.1% | 356.4% | 173.9% | -1,598.3% | – | – | – | – | – | |
| 1,707.6% | 1,450.6% | 21,326.0% | 29.4% | 10.5% | 733.6% | 5,544.4% | -1.4% | – | – | – | – | – | |
| 1,464.9% | 210.1% | 16,622.4% | -4,415.9% | -335.5% | -446.2% | 3,905.1% | -2,830.1% | – | – | – | – | – | |
| -242.6% | -465.4% | -1,295.8% | -1,088.9% | -1,227.0% | -1,586.4% | -1,938.5% | -1,253.0% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.